The COVID-19 pandemic has seen over six million deaths globally, but huge numbers of people have refused immunisation due to doubts surrounding how the vaccines have been produced, evaluated and tested. It’s the most recent example of how important it is to build trust and acceptance when it comes to public health.
Ajibola Omakanye, or Jib, is a trained clinician and researcher specialising in vaccines and immunology, and an online MBA student at UCL School of Management.
As Scientific Officer of Epidemic-Prone Diseases at the European Centre for Disease Prevention and Control (ECDC), Jib has been heavily involved in managing the COVID-19 pandemic, translating a wealth of knowledge and data into evidence that is easily understood for policymakers and the public.
Studying his online MBA during the pandemic, Jib was able to apply his long-term experience in epidemic-prone diseases and his new business management expertise to a huge global problem in real time. The blending of scientific and business knowledge is helping Jib to take his experience out of the lab and into a creative start-up that aims to make scientific research more trusted by and accessible to the public.
Unleashing potential in the sector
In any area of public health, engagement is hugely important. Jib said: “When it comes to introducing a new drug or vaccine, public engagement is what helps people to understand the technology, the reason for the treatment and its impact. All of that improves acceptance and builds trust.
“Infectious diseases are a constant risk to human health, but scientists and researchers aren’t necessarily trained with the business knowledge to pitch their work to investors or to translate their ideas into tangible innovations that are more likely to reach the public eye.”
“If we can channel the right resources to them though, there are opportunities to address those risks and bring the public on board. So, I felt that an MBA would provide me with the formal management training to bring more potential into the vaccine and immunology field.”
Jib’s current venture is a platform that will harness the power of information to allow people to critically assess sources of news and research, as a response to the increasing ‘infodemic’ of misinformation and fake news.
“It will take a data driven approach to consider how we can make better tools to help people access valuable and trustworthy information and ensure people are less at risk of having misinformation influence key decisions in their lives,” Jib said.



Get closer to your dream programme
Your consent preferences have been set.
Time to start exploring.
Your account has been removed.
You can still browse the site or sign up again once you have parental consent.
Get closer to your dream programme